Esperion Therapeutics shares owned by Pentwater Capital Management
Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Pentwater Capital Management
from 13F filings
Historical chart of Pentwater Capital Management investment in Esperion Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Esperion Therapeutics held by Pentwater Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Esperion Therapeutics by Pentwater Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $299k | 181k | 1.65 |
2024-06-30 | $403k | 181k | 2.22 |
2023-06-30 | $252k | 181k | 1.39 |
2023-03-31 | $288k | 181k | 1.59 |
2022-12-31 | $873k | 140k | 6.23 |
2022-09-30 | $1.7M | 255k | 6.70 |
2022-06-30 | $2.1M | 324k | 6.36 |
2022-03-31 | $1.7M | 358k | 4.64 |
2021-12-31 | $1.8M | 363k | 5.00 |
2021-06-30 | $6.1M | 289k | 21.15 |
2021-03-31 | $17M | 608k | 28.05 |
2020-12-31 | $13M | 498k | 26.00 |
2020-09-30 | $81M | 2.2M | 37.17 |
2020-06-30 | $115M | 2.2M | 51.31 |
2020-03-31 | $73M | 2.3M | 31.53 |
2019-12-31 | $134M | 2.3M | 59.63 |
2019-09-30 | $91M | 2.5M | 36.66 |
2019-06-30 | $113M | 2.4M | 46.52 |
2019-03-31 | $99M | 2.5M | 40.15 |
2018-12-31 | $114M | 2.5M | 46.00 |
2018-09-30 | $104M | 2.4M | 44.37 |
2018-06-30 | $97M | 2.5M | 39.19 |
2018-03-31 | $167M | 2.3M | 72.33 |
2017-12-31 | $127M | 1.9M | 65.84 |
2017-09-30 | $112M | 2.2M | 50.12 |
2017-06-30 | $92M | 2.0M | 46.28 |
2017-03-31 | $65M | 1.8M | 35.31 |
2016-12-31 | $23M | 1.8M | 12.52 |
2016-09-30 | $21M | 1.5M | 13.85 |
2016-06-30 | $15M | 1.5M | 9.88 |
2016-03-31 | $24M | 1.4M | 16.91 |
2015-12-31 | $32M | 1.4M | 22.26 |
2015-09-30 | $34M | 1.5M | 23.59 |
2015-06-30 | $124M | 1.5M | 81.76 |
2015-03-31 | $120M | 1.3M | 92.60 |
2014-12-31 | $59M | 1.5M | 40.44 |
2014-09-30 | $24M | 990k | 24.46 |
2014-06-30 | $16M | 1.0M | 15.84 |
2014-03-31 | $13M | 886k | 15.12 |
2013-12-31 | $8.8M | 642k | 13.74 |
2013-09-30 | $8.1M | 431k | 18.86 |
More positions owned by Pentwater Capital Management
View all positions for Pentwater Capital Management